The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Qatar’s VC (venture capital) funding reported a remarkable 135% year-on-year rise to an all-time high of QR115mn in 2024, ...

Singapore government sovereign wealth fund Temasek’s subsidiary, Vertex Ventures, is set to lead a $50-60 million funding ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $407 from $402 and keeps a Sector Perform rating on the shares.

Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...

Some of the most active venture capital firms in Latin America are planning to invest more in startups that offer loans and ...

Corporate Venture Capital (CVC) investment is an increasingly used strategic tool that enables large corporations to make ...

This latest initiative raises Hitachi’s total investment in CVC to $1 billion, reinforcing its commitment to identifying and ...

The venture capital market in Jamaica and the broader Caribbean has long been seen as an underutilised tool for economic transformation. While the concept of high-growth start-ups receiving ...

Despite "another impressive quarterly revenue beat" on Tuesday and solid guidance, Vertex stock dipped on light profit.